BridgeBio Oncology Therapeutics logo
BridgeBio Oncology Therapeutics
BBOT | NASDAQ
Chart Builder DCF Calculator
$1.98
-$0.16 (-7.48%)
At close: Nov 16, 2026, 4:00 PM ET
$2.01
+$0.03 (+1.52%)
After-hours: Nov 16, 2026, 7:00 PM ET

BridgeBio Oncology Therapeutics Institutional Ownership

Institutional ownership explained

Institutional Ownership

Net Inflow
Dollar & Volume Weighted
Total Institutions
67
Total Ownership
74219.11%
Capital Flow
+$61.06M
Shares Change
+1.98M
Ownership Distribution
Institutions (99.99%)
Others (0.01%)

Institutional Sentiment

Overall: bullish
Equity Sentiment & Activity
bullish
New Positions
18
Increased Positions
39
Reduced Positions
14
Closed Positions
18
New (18)
Increased (39)
Reduced (14)
Closed (18)

Super Investors

Super Investor / Fund Ownership Portfolio Weight Shares Market Value
Moore Capital Management LP
124.92%
0.00%
0.02%
100K
923K

Top Shareholders

Institution Ownership Portfolio Weight Shares Market Value
Cormorant Asset Management, LP
22333.17%
-0.03%
6.98%
-13.13%
17.88M
0.00%
136.23M
-14.86%
Deerfield Management Company, L.p.
6102.69%
-0.03%
0.39%
-24.72%
4.89M
0.00%
37.23M
-14.86%
Omega Fund Management, LLC
4109.30%
-0.03%
13.50%
-25.19%
3.29M
0.00%
25.07M
-14.86%
Pro Membership

Stop Guessing, Start Knowing.

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access

Unlimited access to all data and tools, giving you the edge over everyone else in the market.

Proprietary Stock Rating Score

Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.

Top Wall Street Analyst Ratings

Follow ratings from the best analysts on Wall Street to stay ahead of market moves.

Up to 30 years financial history

We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.